Catalyst Wire Dossier Catalyst Wire Dossier

Tocilizumab biosimilar

tocilizumab · Fresenius Kabi SwissBioSim GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tocilizumab biosimilar, covering 2025-09-11 to 2025-09-11. Get the full timeline:

Most recent: Clinical Trial Update: Real World Use of Tocilizumab Biosimilar studY

See pricing